Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Prostate Cancer
Would you offer modest hypofractionation (e.g. 70 Gy/28 fractions) to a patient with intermediate risk prostate cancer and celiac disease?
Answer from: Radiation Oncologist at Community Practice
Celiac disease is primary small bowel disease. RT effect on rectum would not be exaggerated from the disease.
Sign in or Register to read more
5901
Related Questions
Are there any contraindications to Pluvicto therapy you personally use, given that there are none directly provided by the manufacturer?
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
Which patients, if any, do you offer transdermal estradiol as a method of ADT instead of LHRH agonists?
For a patient post-prostatectomy with a high PSA (>1), a negative MRI pelvis, and a negative PSMA PET scan, do you pursue any other imaging?
Why are patients getting enzalutamide s/p prostatectomy not candidates for salvage radiation therapy?
In post-prostatectomy patients where urinary continence is never achieved, how and when would you plan RT when it is clinically indicated?
Would you ever omit or reduce prostate bed radiation in a post-prostatectomy patient who develops recurrence in pelvic LNs?
Would you offer salvage radiation for a local recurrence of prostate cancer that was initially treated with SBRT?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
When treating prostate cancer with moderate hypo-fractionation, what urethral dose constraints do you consider when boosting the dominate intraprostatic lesion?